Joyce Hu

Joyce Hu is an accomplished professional in the field of cancer biology and immunology with extensive experience in research and leadership roles. Currently serving as Managing Editor at the Journal of Translational Medicine and Vice President, Head of Cancer Biology at Sonata Therapeutics, Joyce is focused on developing innovative cancer therapies. Previous positions include Director of Cell Therapy at both BioNTech SE and Kite Pharma, where contributions involved biomarker and T cell discovery. Joyce's expertise is rooted in academic research with postdoctoral roles at the La Jolla Institute of Allergy and Immunology and UCSF, where significant projects included gene editing and T cell migration studies. Joyce holds a Ph.D. in Biomedical Sciences-Immunology from the University of California, San Francisco, and a BA in Music from the University of California, Berkeley.